circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis
Aging · 2023
DOI: 10.18632/aging.205244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Linling Ju und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Nantong University, Nantong University, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People`s Hospital, Nanto…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Nantong University, Nantong University, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People`s Hospital, Nantong 226000, Jiangsu, China.
- Department of Gastroenterology, Changshu Second People’s Hospital, Changshu 215500, Jiangsu, China.
- Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China.
Zitieren
APA
Ju, L., Zhou, Q., Qi, Q., She, Y., Cai, W., Cao, Y., Lu, R., Shao, J., & Chen, L. (2023). circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. Aging. https://doi.org/10.18632/aging.205244
Vancouver
Ju L, Zhou Q, Qi Q, She Y, Cai W, Cao Y, et al. circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. Aging. 2023. doi:10.18632/aging.205244
BibTeX
@article{Ju2023,
author = {Ju, Linling and Zhou, Qian and Qi, Qianyi and She, Yongjun and Cai, Weihua and Cao, Yali and Lu, Rujian and Shao, Jianguo and Chen, Lin},
title = {circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205244}
}
EUVIMED